Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase

Hemasphere. 2020 Aug 10;4(4):e448. doi: 10.1097/HS9.0000000000000448. eCollection 2020 Aug.

Chiara Oltolini¹, Anna Guidetti^{2

3}, Marco Ripa^{1

4}, Barbara Castiglioni¹, Chiara Tassan Din¹, Sara Mastaglio⁵, Diana Canetti¹, Giacomo Monti⁶, Andrea Andolina¹, Chiara Molinari⁷, Antonella Poloniato⁸, Andrea Mastrangelo^{1

4}, Marica Ferrante^{9

4}, Marco Lanzillotta^{9

4}, Paolo Scarpellini¹, Antonella Castagna^{1

4}, Paolo Corradini^{2

3}, Fabio Ciceri^{5

4}

¹ Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
² Hematology and Bone Marrow Transplant, Istituto Nazionale Tumori, Milan, Italy.
³ Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.
⁴ University Vita-Salute San Raffaele, Milan, Italy.
⁵ Hematology and Bone Marrow Transplant, San Raffaele Scientific Institute, Milan, Italy.
⁶ Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy.
⁷ Department of General Medicine, Endocrine and Metabolic Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
⁸ Neonatal Unit, San Raffaele Scientific Institute, Milan, Italy.
⁹ Department of General Medicine, San Raffaele Scientific Institute, Milan, Italy.

No abstract available